window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : February 16, 2026

  • News
  • About Us
Contact Us

solid tumors

  • Cell & Gene Therapy,Clinical Development,Oncology,Partnerships & Funding,Research & Development

    CuraCell highlights T-cell therapy advances for solid tumors on World Cancer Day

    On World Cancer Day (today, February 4), CuraCell highlights its [...]

    February 4, 2026
  • Biologics & Biosimilars,Biotech,Clinical Development,Clinical Trials,Drug Development,Oncology,Pharmaceuticals and therapeutics,Research & Development

    Bicara announces Phase 3 optimal dose for ficerafusp alfa and provides 2026 corporate outlook

    Bicara Therapeutics has selected 1500 mg of ficerafusp alfa as [...]

    January 13, 2026
  • Biologics & Biosimilars,Biotech,Clinical Development,Drug Development,Oncology,Partnerships & Funding,Pharmaceuticals and therapeutics

    Lonza’s Synaffix and Sidewinder enter multi-target license agreement for bispecific ADCs

    Synaffix B.V., a Lonza company focused on clinical-stage antibody-drug conjugate [...]

    January 7, 2026
  • CDMOs & Manufacturing,Cell & Gene Therapy,Rare Diseases,Research & Development

    University of Minnesota investigators awarded $665,000 in ScaleReady G-Rex Grant funding

    Three research teams to advance manufacturing and development of cell [...]

    August 1, 2025
  • Clinical Trials,Drug Delivery & Formulation,Oncology,Patient Centricity,Precision medicine,Technology and platforms

    Can cryoablation plus intratumora immunotherapy rewrite the rules of cancer treatment?

    Q&A with Dr Jason Williams, founder of the Williams Cancer [...]

    June 26, 2025
  • Cell & Gene Therapy,Drug Development

    Domain Therapeutics shares updates on immuno-oncology programs at AACR 2025

    May 1, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • SPT Labtech and BellBrook Labs unveil high-throughput screening platform targeting VPS4B in cancer research
    Categories: Biotech, Drug Development, Oncology, Research & Development, Technology and platforms
  • BNPP AM Alts invests $115M in ILiAD Biotechnologies to advance whooping cough vaccine
    Categories: Biotech, Global health, Immunology, Pharmaceuticals and therapeutics, Research & Development
  • Kainova Therapeutics raises $32m CAD Series B to advance immuno-oncology and inflammation pipeline
    Categories: Funding, Oncology, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top